Aerosol formulations containing propellant 134a and fluticasone propionate
Patent 5658549 Issued on August 19, 1997. Estimated Expiration Date: 
May 19, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 19, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2868691 2885427 3014844 3219533 3320125 3809294 3897779 Steroidal aerosol compositions and process for the preparation thereof Aerosol propellant compositions Process for the preparation of a mixture of an anti-inflammatory steroid and a fluoro-chloro-hydrocarbon to be used as a propellant InventorsAssigneeApplicationNo. 444925 filed on 05/19/1995US Classes:424/45, Organic pressurized fluid424/47Topical live body grooming or adorning aid (e.g., hair spray, antiperspirant, etc.)ExaminersPrimary: Bawa, RajAttorney, Agent or FirmForeign Patent References
International ClassA61K 009/12Foreign Application Priority Data1991-12-12 GBAbstractThis invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate medicament selected from the group comprising salmeterol, salbutamol, fluticasone propionate and physiologically acceptable salts and solvates thereof and a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant, which formulation is substantially free of surfactant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.Other References
| |
